ATF Streamlines Gun Dealer Record Forms Update
Published Date: 5/5/2025
Notice
Summary
The ATF is updating the paperwork rules for dealers, pawnbrokers, and collectors of certain firearms to keep records clear and easy to follow. This affects businesses and collectors who handle specific types of guns, making sure they stay on the right side of the law. The update asks for approval soon and aims to keep things smooth without extra costs or delays.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Firearm Dealer and Collector Records Update
If you are a Type 01 or Type 02 firearms dealer or pawnbroker, or a Type 03 firearms collector, the ATF is updating the paperwork rules for records of acquisition and disposition to keep records clearer and easier to follow. The ATF is submitting this information-collection request to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act. The notice says the update aims to keep recordkeeping smooth without extra costs or delays.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-12144 — Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Wedgewood Pharmacy LLC wants to become an official importer of certain strong controlled substances, like Etorphine HCL and Thiafentanil. This affects drug manufacturers and others in the supply chain who can comment or request a hearing by July 17, 2026. No direct costs are mentioned, but the decision could impact how these drugs enter the U.S. market.
2026-12213 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement With Change to a Previously Approved Collection Title-International Terrorism Victim Expense Reimbursement Program Application
The Department of Justice is bringing back and updating the application form for the International Terrorism Victim Expense Reimbursement Program. This affects victims of international terrorism who seek help covering their expenses. The DOJ wants your feedback by July 17, 2026, to make sure the form is clear, useful, and easy to fill out—no extra hassle or hidden costs involved!
2026-12143 — Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
AndersonBrecon, Inc. DBA PCI Pharma Services wants to become an official importer of certain controlled substances, including some strong drugs like tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could impact how these substances are brought into the U.S., but no costs or fees were mentioned yet.
Previous / Next Documents
Previous: 2025-07715 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Furnishing of Explosives Samples
The ATF is asking to keep collecting info about giving out explosives samples, making sure everything stays safe and clear. This affects businesses and folks who handle explosives, and the paperwork rules won’t change or cost extra. They’re just making sure the process stays smooth and approved for a little longer.
Next: 2025-07717 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Request for Temporary Eligibility To Hold a Sensitive Position-ATF Form 8620.69
The ATF is updating a form that helps decide if someone can hold a sensitive job. This change affects people applying for special security clearances and aims to make the process smoother. They’re asking for approval soon, so expect some paperwork updates but no big cost changes.